Healthcare provider profile · identity verified

Benjamin P. Ha, MD

Family Practice · BAKERSFIELD, CA · NPI 1356418206

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	618	219
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	438	113
Amlodipine Besylate	Amlodipine Besylate	363	125
Rosuvastatin Calcium	Rosuvastatin Calcium	319	114
Losartan Potassium	Losartan Potassium	313	108
Ozempic	Semaglutide	296	53
Levothyroxine Sodium	Levothyroxine Sodium	294	92
Metformin Hcl	Metformin Hcl	229	74
Lisinopril	Lisinopril	205	83
Tamsulosin Hcl	Tamsulosin Hcl	191	64
Pantoprazole Sodium	Pantoprazole Sodium	188	69
Omeprazole	Omeprazole	185	61
Metformin Hcl Er	Metformin Hcl	168	66
Gabapentin	Gabapentin	159	47
Atenolol	Atenolol	133	46
Hydrochlorothiazide	Hydrochlorothiazide	133	53
Meloxicam	Meloxicam	132	47
Trazodone Hcl	Trazodone Hcl	126	44
Alendronate Sodium	Alendronate Sodium	123	46
Albuterol Sulfate Hfa	Albuterol Sulfate	122	67
Glipizide	Glipizide	122	47
Tramadol Hcl	Tramadol Hcl	120	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	117	39
Alprazolam	Alprazolam	111	19
Simvastatin	Simvastatin	108	40
Potassium Chloride	Potassium Chloride	104	40
Clopidogrel	Clopidogrel Bisulfate	90	37
Metoprolol Succinate	Metoprolol Succinate	89	38
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	88	18
Furosemide	Furosemide	85	39
Pradaxa	Dabigatran Etexilate Mesylate	80	26
Temazepam	Temazepam	78	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	26
Pravastatin Sodium	Pravastatin Sodium	74	23
Allopurinol	Allopurinol	72	24
Metoprolol Tartrate	Metoprolol Tartrate	71	26
Glipizide Er	Glipizide	68	23
Jardiance	Empagliflozin	67	25
Ibuprofen	Ibuprofen	65	30
Terazosin Hcl	Terazosin Hcl	63	21
Fluoxetine Hcl	Fluoxetine Hcl	61	22
Montelukast Sodium	Montelukast Sodium	61	21
Escitalopram Oxalate	Escitalopram Oxalate	58	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	48	24
Cephalexin	Cephalexin	44	33
Sertraline Hcl	Sertraline Hcl	43	14
Acyclovir	Acyclovir	42	15
Duloxetine Hcl	Duloxetine Hcl	41	15
Humulin N	Insulin Nph Human Isophane	41	17
Triamcinolone Acetonide	Triamcinolone Acetonide	41	20
Finasteride	Finasteride	40	18
Bisoprolol Fumarate	Bisoprolol Fumarate	38	12
Lorazepam	Lorazepam	37	12
Ezetimibe	Ezetimibe	36	15
Ondansetron Odt	Ondansetron	35	15
Victoza 2-Pak	Liraglutide	35	15
Acetaminophen-Codeine	Acetaminophen With Codeine	34	12
Famotidine	Famotidine	34	16
Hydralazine Hcl	Hydralazine Hcl	34	13
Victoza 3-Pak	Liraglutide	32	suppressed
Estradiol	Estradiol	31	13
Humulin N Kwikpen	Insulin Nph Human Isophane	31	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	30	30
Azelastine Hcl	Azelastine Hcl	30	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Carvedilol	Carvedilol	30	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	27	26
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	12
Fenofibrate	Fenofibrate	26	suppressed
Hydrocortisone	Hydrocortisone	26	13
Oxybutynin Chloride Er	Oxybutynin Chloride	26	11
Nystatin	Nystatin	25	12
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	15
Naproxen	Naproxen	24	11
Pregabalin	Pregabalin	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Lactulose	Lactulose	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	20	11
Amoxicillin	Amoxicillin	19	18
Methocarbamol	Methocarbamol	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Prednisone	Prednisone	19	17
Promethazine Hcl	Promethazine Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Eliquis	Apixaban	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Nitroglycerin	Nitroglycerin	17	11
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Liraglutide	Liraglutide	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Fluconazole	Fluconazole	14	11
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Ssd	Silver Sulfadiazine	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Tadalafil	Tadalafil	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error